Browsing
     by title


0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

or enter first few letters:   
OK
Full Text
Peer Reviewed
See detailComa, Persistent Vegetative States, and Diminished Consciousness
Demertzi, Athina ULg; Laureys, Steven ULg; Boly, Mélanie ULg

in Encyclopedia of Consciousness (2009), 1

Detailed reference viewed: 76 (14 ULg)
Full Text
See detailLe combat laïque contre l'extrême droite
Jacquemain, Marc ULg

in Pensée et les Hommes (La) (2008), 68

The paper defends that the campaign of secularist movement against resurgence of right-wing extremism, although animated by very good intentions, is fragile on two points : it gives too much emphasis on ... [more ▼]

The paper defends that the campaign of secularist movement against resurgence of right-wing extremism, although animated by very good intentions, is fragile on two points : it gives too much emphasis on the denunciation of a historical past that is no longer reclaimed by the far right itself and too little on the learning processes necessary to foster democracy; and on the other hand, this struggle may appear partial and one sided because the fight against right-wing extremism is not a monopoly of the secularist movement. [less ▲]

Detailed reference viewed: 46 (10 ULg)
Full Text
Peer Reviewed
See detailLe ‘combat pour l’intégration’ des églises congolaises (RDC) d’obédience pentecôtiste
Demart, Sarah ULg

in Revue Européenne des Migrations Internationales (2008), 24(3), 147-165

This article proposes to analyse the discourses on “integration” developed during the last few years within various “ethnics” churches (France-Belgium). Of Pentecostal and Evangelical obedience, these ... [more ▼]

This article proposes to analyse the discourses on “integration” developed during the last few years within various “ethnics” churches (France-Belgium). Of Pentecostal and Evangelical obedience, these churches, stemming from Congolese’s migrations (DRC), can be estimated to several hundreds and even up to a few thousands in Europe. Some constant can be observed in this new branch of Protestantism despite its fragmented and plural movement, particularly the right to think oneself beyond the logics of reduction to otherness. The integrationist discourse produced constitutes a real break with the ideas carried by the autochthon order of both hierarchies and centralities. [less ▲]

Detailed reference viewed: 59 (26 ULg)
See detailCombating Child Labour in Burkina Faso: Are the public policies dealing with the impossible?
Wouango, Joséphine ULg

Conference (2011, April 07)

These last years, the objective of abolishing child labour in Burkina Faso (a West African country) has tried to create a national unanimity regarding the commitment of collective actors (decision-makers ... [more ▼]

These last years, the objective of abolishing child labour in Burkina Faso (a West African country) has tried to create a national unanimity regarding the commitment of collective actors (decision-makers, civil society, employers, labor unions and media). It started by integrating the National Program of child welfare and the schedule of the Ministry of Employment, Ministry of Social Action, and the Ministry of Education. Burkina Faso joined the International Programme on the Elimination of Child Labour (IPEC) in 1999, created a department of fight against child labour in 2006 and raised the minimum age for admission to employment from 14 to 16 years. This paper supports a critical view of global actions to fight child labour and discusses the complexities of this issue in Burkina Faso. Using an analysis of the State’s National Plan of Action on the elimination of child Labour and two local cases studies on projects that are aimed at removing children from their work, it shows how the local context of working children and their parents are ignored in order to comply with international policy agenda and to cater to donor demands. [less ▲]

Detailed reference viewed: 38 (6 ULg)
Full Text
Peer Reviewed
See detailCombating the dual burden: therapeutic targeting of common pathways in obesity and type 2 diabetes
SCHEEN, André ULg; Van Gaal, Luc

in The Lancet Diabetes & Endocrinology (2014)

The increasing prevalence of obesity is contributing substantially to the ongoing epidemic of type 2 diabetes. Abdominal adiposity, a feature of ectopic fat syndrome, is associated with silent ... [more ▼]

The increasing prevalence of obesity is contributing substantially to the ongoing epidemic of type 2 diabetes. Abdominal adiposity, a feature of ectopic fat syndrome, is associated with silent inflammation, abnormal hormone secretion, and various metabolic disturbances that contribute to insulin resistance and insulin secretory defects, resulting in type 2 diabetes, and induce a toxic pattern that leads to cardiovascular disease, liver pathologies, and cancer. Despite the importance of weight control strategies in the prevention and management of type 2 diabetes, long-term results from lifestyle or drug interventions are generally disappointing. Furthermore, most of the classic glucose-lowering drugs have a side-effect of weight gain, which renders the management of most overweight or obese people with type 2 diabetes even more challenging. Many anti-obesity pharmacological drugs targeting central control of appetite were withdrawn from the market because of safety concerns. The gastrointestinal lipase inhibitor orlistat was the only anti-obesity drug available until the recent US, but not European, launch of phentermine–controlled-release topiramate and lorcaserin. Improved knowledge about bodyweight regulation opens new prospects for the potential use of peptides derived from the gut or the adipose tissue. Combination therapy will probably be necessary to avoid compensatory mechanisms and potentiate initial weight loss while avoiding weight regain. New glucose-lowering treatments, especially glucagon-like peptide-1 receptor agonists and sodium glucose cotransporter-2 inhibitors, offer advantages over traditional antidiabetic drugs by promoting weight loss while improving glucose control. In this Review, we explore the overlapping pathophysiology and also how various treatments can, alone or in combination, combat the dual burden of obesity and type 2 diabetes. [less ▲]

Detailed reference viewed: 142 (2 ULg)
See detailLes combattants européens en Syrie
Flore, Daniel ULg; Jacobs, Ann ULg

Book published by L'Harmattan (2015)

Detailed reference viewed: 10 (1 ULg)
Full Text
See detailLes combattants terroristes étrangers : vers un déplacement des frontières en droit international pénal ?
Flore, Daniel ULg

in Jacobs, Ann; Flore, Daniel (Eds.) Les combattants européens en Syrie (2015)

Cette contribution constitue la conclusion de l'ouvrage. Elle montre comment la nouvelle notion de "combattants terroristes étrangers" remet en question les frontières entre le domaine du droit des ... [more ▼]

Cette contribution constitue la conclusion de l'ouvrage. Elle montre comment la nouvelle notion de "combattants terroristes étrangers" remet en question les frontières entre le domaine du droit des conflits armés et celui du droit commun du terrorisme. [less ▲]

Detailed reference viewed: 13 (0 ULg)
See detailCombattre plume à la main plutôt que glaive au poing
Close, Florence ULg

Conference given outside the academic context (2015)

Detailed reference viewed: 15 (1 ULg)
Full Text
See detailCombien de litres de kérosène dans notre assiette?
Ozer, Pierre ULg; Perrin, Dominique ULg

Article for general public (2008)

L’aviation commerciale émet près de 5% des émissions mondiales de CO2 dues aux activités humaines. Sa part ne fait qu’augmenter et le développement de la mobilité internationale des biens et des personnes ... [more ▼]

L’aviation commerciale émet près de 5% des émissions mondiales de CO2 dues aux activités humaines. Sa part ne fait qu’augmenter et le développement de la mobilité internationale des biens et des personnes laisse présager une prolongation des tendances historiques de croissance du transport aérien. Avec comme conséquence, une assiette de plus en plus lourde en CO2 lorsque nos aliments proviennent de contrées lointaines par voie aérienne (kérosène). [less ▲]

Detailed reference viewed: 73 (9 ULg)
Full Text
See detailCombinaison d'informations génomiques, phénotypiques et généalogiques
Vandenplas, Jérémie ULg; Gengler, Nicolas ULg

Conference given outside the academic context (2013)

Detailed reference viewed: 23 (12 ULg)
See detailCombinaison de la radiographie et de l'échographie pour l'examen du grasset sur le terrain
Busoni, Valeria ULg

in Proceedings de la Journée de la Belgian Equine Practitioners Society (BEPS) (2003)

Detailed reference viewed: 15 (0 ULg)
Full Text
Peer Reviewed
See detailCombinaison fixe atorvastatine-ezetimibe (Atozet(R)).
Scheen, André ULg

in Revue medicale de Liege (2016), 71(1), 47-52

Cardiovascular prevention in subjects at high or very high risk requires a drastic reduction in LDL cholesterol according to the concept "the lower, the better". The combination of an inhibitor of ... [more ▼]

Cardiovascular prevention in subjects at high or very high risk requires a drastic reduction in LDL cholesterol according to the concept "the lower, the better". The combination of an inhibitor of cholesterol synthesis and a selective inhibitor of intestinal absorption results in a complementary and synergistic LDL-lowering activity. Besides a first fixed combination ezetimibe-simvastatin (Inegy(R)), a new fixed combination is presented, Atozet(R) that combines atorvastatin and ezetimibe. Because atorvastatin is more potent than simvastatin, this novel fixed combination should facilitate reaching therapeutic goals in terms of LDL cholesterol amongst patients with severe hypercholesterolaemia and/or at high or very high cardiovascular risk. [less ▲]

Detailed reference viewed: 28 (4 ULg)
Full Text
Peer Reviewed
See detailCombinaison fixe perindopril-amlodipine (Coveram®) dans le traitement de l'hypertension artérielle et de l'insuffisance coronaire.
Scheen, André ULg; Krzesinski, Jean-Marie ULg

in Revue Médicale de Liège (2009), 64(4), 223-227

Coveram® is a new fixed combination of an angiotensin converting enzyme inhibitor, perindopril, and a calcium antagonist, amlodipine. This new medication is indicated for the treatment of arterial ... [more ▼]

Coveram® is a new fixed combination of an angiotensin converting enzyme inhibitor, perindopril, and a calcium antagonist, amlodipine. This new medication is indicated for the treatment of arterial hypertension and/or stable coronary heart disease. Such fixed combination of two molecules that have been extensively evaluated according to evidence-based medicine offers the advantage of an excellent efficacy, associated with a good tolerance profile, and favours patient’s compliance. The marketing of different formulations of Coveram® combining various dosages allows easy adjustment and titration of each of the components according to the individual patient’s characteristics. [less ▲]

Detailed reference viewed: 485 (17 ULg)
Full Text
Peer Reviewed
See detailCombinaison fixe perindopril-indapamide-amlodipine (Triplixam) pour le traitement de l'hypertension arterielle.
Scheen, André ULg; Lancellotti, Patrizio ULg; Krzesinski, Jean-Marie ULg

in Revue medicale de Liege (2014), 69(10), 565-70

Triplixam is a fixed dose combination of three well known antihypertensive agents, with complementary activities, to control blood pressure in patients with arterial hypertension: perindopril, an ... [more ▼]

Triplixam is a fixed dose combination of three well known antihypertensive agents, with complementary activities, to control blood pressure in patients with arterial hypertension: perindopril, an angiotensin converting enzyme inhibitor, indapamide, a diuretic whith thiazide-like effects but also specific properties, and amlodipine, a long-acting calcium antagonist of the dihydropyridine family. The potential synergic action allows better control of blood pressure with once daily administration, while limiting the incidence of adverse events. Various presentations with different dosages are available to facilitate individualized therapy. Warnings and precautions for use of every molecule should of course be respected. Such a fixed dose combination should contribute to limit clinical inertia and to improve therapeutic compliance. [less ▲]

Detailed reference viewed: 42 (0 ULg)